awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37109457-0370FC98-401F-4272-8EC5-AFBA20A2968B
Q37109457-0370FC98-401F-4272-8EC5-AFBA20A2968B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37109457-0370FC98-401F-4272-8EC5-AFBA20A2968B
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS
P2860
Q37109457-0370FC98-401F-4272-8EC5-AFBA20A2968B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37109457-0370FC98-401F-4272-8EC5-AFBA20A2968B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
26cb71d8184ec1ff183ff3fb23ae9d4174c8a6b5
P2860
Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosis.